Sèvis nou yo
Sèvis Maladi Enfektye
Tretman siksè kòmanse ak yon dyagnostik egzat. Ekspè maladi enfeksyon nou yo pran tan pou fè li byen.
Nou ofri sèvis konplè dyagnostik, konsiltasyon, ak tretman pou moun ki gen maladi ki te koze pa òganis oswa patojèn, tankou viris, bakteri, fongis, ak parazit.
Ekip nou an gen anpil konesans sou enfeksyon senp ak miltisistemik, tankou:
Hepatitis C (HCV) Program
- Program established in 2021
- Serving nearly 350 patients with chronic hepatitis C, 83% began treatment with 98% of those who started completing treatment
STI Testing and Treatment along with Preventative Services
- Pre-exposure prophylaxis to prevent HIV (PrEP) and other STIs including chlamydia, gonorrhea, and syphilis (doxy PEP)
- Post-exposure prophylaxis to prevent HIV after health care related exposures and non-health care related exposures
Treatment for Common and Complex Infections
- Management of recurrent UTIs, bone and soft tissue infections, gastrointestinal infections, pneumonias, sinusitis, fevers of unknown origin, and any other infection
Injectable Treatments
- Patient Reach: Nearly 50 patients on injectable medications.
- Common Injectable Medications: Apretude & Cabenuva

Mary Louise Decker, M.D., FIDSA, is a board-certified infectious disease physician and Infectious Disease Medical Director for The Wright Center for Community Health.